MIC therapy: New topical immune modulating therapy against melanoma

Melanoma is among the most aggressive forms of cancer, with some 138,000 people diagnosed every year in the western world alone. The large majority of melanoma patients are diagnosed in locally advanced or metastatic stage of disease and the only available treatments yield poor or at best transient


Click here for more information on this collaboration opportunity